Champions TumorGraft® PDX Models Used in Clinical and Research Settings Featured at AACR Annual Meeting

Hackensack, NJ – April 18, 2015 – Champions Oncology, Inc. (OTC : CSBR) a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced the presentation of data from applications of Champions TumorGraft® PDX models in clinical and research settings at the American Association for Clinical Research (AACR) Annual Meeting 2015.

The presentations will be delivered by addressing delegates as well as during general poster sessions at the Philadelphia Convention Center between Saturday, April 18 and Wednesday, April 22.